Please note that Fresenius Medical's price fluctuation is very steady at this time. Calculation of the real value of Fresenius Medical Care is based on 3 months time horizon. Increasing Fresenius Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Fresenius stock is determined by what a typical buyer is willing to pay for full or partial control of Fresenius Medical Care. Since Fresenius Medical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Fresenius Stock. However, Fresenius Medical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical
Market 41.51
Real 40.24
Hype 41.51
Naive 40.88
The intrinsic value of Fresenius Medical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Fresenius Medical's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Fresenius Medical Care helps investors to forecast how Fresenius stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Fresenius Medical more accurately as focusing exclusively on Fresenius Medical's fundamentals will not take into account other important factors:
Fresenius Medical Care is presently projected to have takeover price of 23.21 B with market capitalization of 17.87 B, debt of , and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Fresenius Medical fundamentals before making investing decisions based on enterprise value of the company
About 32.0% of the company shares are owned by insiders or employees . The company had not issued any dividends in recent years. Fresenius Medical Care had 3:1 split on the 18th of June 2007. Based on the analysis of Fresenius Medical's profitability, liquidity, and operating efficiency, Fresenius Medical Care is not in a good financial situation at this time. It has a very high probability of going through financial hardship in January.
One of the ways to look at asset utilization of Fresenius is to check how much profit was generated for every dollar of assets it reports. Fresenius Medical Care utilizes its assets almost 0.0298 percent, getting 0.0298 cents for each dollar of assets held by the firm. An increasing asset utilization denotes the company is being more effective with each dollar of assets it shows. Put another way, asset utilization of Fresenius Medical shows how effective it operates for each dollar spent on its assets.
Covid
Fresenius Medical Ownership Allocation
The market capitalization of Fresenius Medical Care is USD17.87 Billion. Fresenius Medical Care retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please take into account that even companies with profitable outlook can generate negative future returns on their equity. If the true value of the firm is less than the current market value, you may not be able generate positive returns on investment in the long run.
Fresenius Medical Profitability Analysis
The company reported the revenue of 19.24 B. Net Income was 499 M with profit before overhead, payroll, taxes, and interest of 5.31 B.
About Fresenius Medical Valuation
The stock valuation mechanism determines Fresenius Medical's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Fresenius Medical Care based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Fresenius Medical. We calculate exposure to Fresenius Medical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Fresenius Medical's related companies.
When running Fresenius Medical's price analysis, check to measure Fresenius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fresenius Medical is operating at the current time. Most of Fresenius Medical's value examination focuses on studying past and present price action to predict the probability of Fresenius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fresenius Medical's price. Additionally, you may evaluate how the addition of Fresenius Medical to your portfolios can decrease your overall portfolio volatility.